Home  >  Products  >  UBL4A (ubiquitin-like 4A) Blocking Peptide (the C terminal of UBL4A)(100ug)
UBL4A (ubiquitin-like 4A) Blocking Peptide (the C terminal of UBL4A)(100ug)

UBL4A (ubiquitin-like 4A) Blocking Peptide (the C terminal of UBL4A)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-UBL4A Antibody, made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP59393
Size: 100ug
Weight: 18kDa
Gene: 8266
Format: Lyophilized powder
Target: UBL4A is a component of the BAT3 complex, a multiprotein complex involved in the post-translational delivery of tail-anchored (TA) membrane proteins to the endoplasmic reticulum membrane. UBL4A is the TA membrane proteins, also named type II transmembrane proteins, contain a single C-terminal transmembrane region. The complex acts by facilitating TA proteins capture by ASNA1/TRC40: it is recruited to ribosomes synthesizing membrane proteins, interacts with the transmembrane region of newly released TA proteins, and transfers them to ASNA1/TRC40 for targeting.
Alternative names: DX254E; DXS254E; G6PD; GDX; UBL4
See Full Product Listings >